FI64597C - Foerfarande foer framstaellning av terapeutiskt anvaendbara 5-ubstituerade 1,2-dihydro-3h-pyrrolo(1,2-a)pyrrol-1-karbox ylyror av motsvarande nya nitriler - Google Patents

Foerfarande foer framstaellning av terapeutiskt anvaendbara 5-ubstituerade 1,2-dihydro-3h-pyrrolo(1,2-a)pyrrol-1-karbox ylyror av motsvarande nya nitriler Download PDF

Info

Publication number
FI64597C
FI64597C FI782307A FI782307A FI64597C FI 64597 C FI64597 C FI 64597C FI 782307 A FI782307 A FI 782307A FI 782307 A FI782307 A FI 782307A FI 64597 C FI64597 C FI 64597C
Authority
FI
Finland
Prior art keywords
pyrrolo
dihydro
pyrrole
nitrile
mixture
Prior art date
Application number
FI782307A
Other languages
English (en)
Finnish (fi)
Other versions
FI64597B (fi
FI782307A (fi
Inventor
Horn Albert R Van
Pasquale G Gallegra
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25225403&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI64597(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of FI782307A publication Critical patent/FI782307A/fi
Publication of FI64597B publication Critical patent/FI64597B/fi
Application granted granted Critical
Publication of FI64597C publication Critical patent/FI64597C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/335—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/337—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FI782307A 1977-07-25 1978-07-21 Foerfarande foer framstaellning av terapeutiskt anvaendbara 5-ubstituerade 1,2-dihydro-3h-pyrrolo(1,2-a)pyrrol-1-karbox ylyror av motsvarande nya nitriler FI64597C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81837777A 1977-07-25 1977-07-25
US81837777 1977-07-25

Publications (3)

Publication Number Publication Date
FI782307A FI782307A (fi) 1979-01-26
FI64597B FI64597B (fi) 1983-08-31
FI64597C true FI64597C (fi) 1983-12-12

Family

ID=25225403

Family Applications (1)

Application Number Title Priority Date Filing Date
FI782307A FI64597C (fi) 1977-07-25 1978-07-21 Foerfarande foer framstaellning av terapeutiskt anvaendbara 5-ubstituerade 1,2-dihydro-3h-pyrrolo(1,2-a)pyrrol-1-karbox ylyror av motsvarande nya nitriler

Country Status (27)

Country Link
US (1) US4140698A (da)
EP (1) EP0000649B1 (da)
JP (1) JPS5424889A (da)
AT (1) AT364843B (da)
AU (1) AU515352B2 (da)
CA (1) CA1111431A (da)
CS (1) CS201015B2 (da)
DD (1) DD137229A5 (da)
DE (1) DE2860560D1 (da)
DK (1) DK146720C (da)
ES (1) ES472002A1 (da)
FI (1) FI64597C (da)
GR (1) GR63733B (da)
HK (1) HK17186A (da)
HU (1) HU178354B (da)
IE (1) IE47138B1 (da)
IL (1) IL55181A (da)
IT (1) IT1160443B (da)
MY (1) MY8800142A (da)
NO (2) NO166863C (da)
NZ (1) NZ187924A (da)
PL (1) PL111419B1 (da)
PT (1) PT68328A (da)
SG (1) SG31884G (da)
SU (1) SU1138029A3 (da)
YU (1) YU40717B (da)
ZA (1) ZA784216B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4232038A (en) * 1979-08-31 1980-11-04 Syntex (U.S.A.) Inc. 5-Alkylsulfinylbenzoyl- and 5-alkylsulfonylbenzoyl-1,2-dihydro-3H-pyrrolo[1,]pyrrole-1-carboxylic acids
ATE7694T1 (de) * 1980-02-14 1984-06-15 Grigg, Ronald Ernest Derivate von 2-methyl-5-thiazolmethylamin und carboxamid.
US4344943A (en) * 1980-06-09 1982-08-17 Syntex (U.S.A.) Inc. 6-Chloro- or 6-bromo-1,2-dihydro-3H-pyrrolo[1,2-a]-pyrrole-1-carboxylic acids and derivatives thereof
US4353829A (en) * 1980-11-21 1982-10-12 Syntex (U.S.A.) Inc. Process for 5-aroylation of 1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic esters
WO1983001382A1 (en) * 1981-10-13 1983-04-28 Mroszczak, Edward Gastrointestinal sparing thioester pro-drugs
US4397862A (en) * 1981-10-13 1983-08-09 Syntex (U.S.A.) Inc. Gastrointestinal sparing thioester drugs
US4454151A (en) * 1982-03-22 1984-06-12 Syntex (U.S.A.) Inc. Use of pyrrolo pyrroles in treatment of ophthalmic diseases
US4457941A (en) * 1982-03-22 1984-07-03 Syntex (U.S.A.) Inc. Use of pyrrolo-pyrrole in treating microvascular diseases associated with diabetes
DE3460315D1 (en) * 1983-02-19 1986-08-28 Beecham Group Plc Benzofuran and benzothiophene-carboxylic-acid derivatives
US4874871A (en) * 1987-03-25 1989-10-17 Syntex (U.S.A.) Inc. Process for preparing (+)-2,3-Dihydro-1H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid and related compounds
JP2649168B2 (ja) * 1988-02-25 1997-09-03 久光製薬株式会社 新規な５，６−ジフェニル−１，２−ジヒドロ−３Ｈ−ピロロ［１，２−ａ］ピロール−１−カルボン酸誘導体
US5804214A (en) * 1993-07-08 1998-09-08 Cygnus, Inc. Monolithic matrix transdermal delivery system for delivering ketorolac tromethamine
US5621115A (en) * 1996-02-21 1997-04-15 Ohmeda Pharmaceutical Products Division Inc. Methods for preparing 5-aroyl-1,2-dihydro-3H-pyrrolo-[1,2-A]pyrrole-1-carboxylic acids
US6191285B1 (en) 1997-07-03 2001-02-20 Abbott Laboratories Process for the preparation of ketorolac tromethamine
JP2002520313A (ja) * 1998-07-10 2002-07-09 マリンクロッド・インコーポレイテッド ケトロラクの製造に有用な化合物の合成

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087539A (en) * 1976-07-14 1978-05-02 Syntex (U.S.A.) Inc. 5-(2-Furoyl)-, 5-(2-thenoyl)-, 5-(3-furoyl)- and 5-(3-thenoyl)-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof
US4089969A (en) * 1976-07-14 1978-05-16 Syntex (U.S.A.) Inc. 5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof
JPS539789A (en) * 1976-07-14 1978-01-28 Syntex Inc Production of 55*22floyl** * 55*22thenoyl** * 55*33 floyl** and 55*33thenoyl** 1*22dihydroo3hhpyroro * 1*22a*pyrolee11carboxylic acid derivative
JPS539788A (en) * 1976-07-14 1978-01-28 Syntex Inc 55aloyll1*22dihydroo3hh pyroro *1*22a* pyroll11 carboxylic acid derivative
US4097579A (en) * 1977-03-31 1978-06-27 Syntex (U.S.A.) Inc. 5-(2-Pyrroyl)-1,2-dihydro-3H-pyrrolo 1,2-a!pyrrole-1-carboxylic acid derivatives and process for the production thereof

Also Published As

Publication number Publication date
HU178354B (en) 1982-04-28
NO155244C (no) 1987-03-04
JPS6337793B2 (da) 1988-07-27
NO166863C (no) 1991-09-11
PL208576A1 (pl) 1979-05-07
IE781473L (en) 1979-01-25
DD137229A5 (de) 1979-08-22
IL55181A0 (en) 1978-09-29
ATA528978A (de) 1981-04-15
DK146720C (da) 1984-08-20
DK146720B (da) 1983-12-12
NO166863B (no) 1991-06-03
SG31884G (en) 1985-09-13
NZ187924A (en) 1980-03-05
NO851935L (no) 1979-01-26
JPS5424889A (en) 1979-02-24
IT1160443B (it) 1987-03-11
US4140698A (en) 1979-02-20
PT68328A (en) 1978-08-01
MY8800142A (en) 1988-12-31
FI64597B (fi) 1983-08-31
GR63733B (en) 1979-12-04
AT364843B (de) 1981-11-25
SU1138029A3 (ru) 1985-01-30
IT7868765A0 (it) 1978-07-24
YU174178A (en) 1983-01-21
EP0000649A1 (en) 1979-02-07
DK325078A (da) 1979-01-26
ZA784216B (en) 1980-02-27
FI782307A (fi) 1979-01-26
EP0000649B1 (en) 1981-03-25
ES472002A1 (es) 1984-07-16
HK17186A (en) 1986-03-21
IE47138B1 (en) 1983-12-28
AU3826978A (en) 1980-01-31
CS201015B2 (en) 1980-10-31
NO155244B (no) 1986-11-24
CA1111431A (en) 1981-10-27
PL111419B1 (en) 1980-08-30
IL55181A (en) 1981-12-31
YU40717B (en) 1986-04-30
NO782545L (no) 1979-01-26
DE2860560D1 (en) 1981-04-16
AU515352B2 (en) 1981-04-02

Similar Documents

Publication Publication Date Title
FI64597C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 5-ubstituerade 1,2-dihydro-3h-pyrrolo(1,2-a)pyrrol-1-karbox ylyror av motsvarande nya nitriler
EP1257553B1 (en) Pyrrolopyrimidinone derivatives, process of preparation and use
US4466976A (en) Antiinflammatory and antiallergic imidazole derivatives
AU2001236140A1 (en) Pyrrolopyrimidinone derivatives, process of preparation and use
NZ511015A (en) 1, 6-Dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one derivatives useful for treating impotence
WO2004072030A2 (en) Process for preparing pyrrolotriazine kinase inhibitors
FI76800C (fi) Foerfarande foer framstaellning av 2-(2-imidazolyl)pyrrolo/3,2-ij/kinoliner och 2-(2-imidazolyl)azepino /3,2,1-hi/indoler, vilka aer antagonister mot 2-adrenergiska receptorer.
US20080009634A1 (en) Process for synthesizing beta-lactamase inhibitor intermediates
US20210292329A1 (en) Methods of preparing indolinobenzodiazepine derivatives
Yao et al. Total syntheses of (+)-agelastatin A and (+)-agelastatin B through cationic cyclizations
Rashid et al. Synthesis of novel 3, 4-fused pyrazolidinone γ-lactam bicyclic moieties from 2, 3-dioxo-4-carboxy-5-(substituted) pyrrolidines
IE42626B1 (en) 6-aryl-2,3,6,7-tetrahydro-5h-pyrrolo (1,2- )-imidazole derivatives, processes for their manufacture and compositions containing them
CA2413761C (en) A process for preparing pyrazolopyrimidinone derivatives for the treatment of impotence
Prešeren et al. Oxidative ring‐opening of rel‐(2R, 3R, 5S)‐5‐aryl‐2‐benzoylamino‐6, 7‐bis (methoxycarbonyl)‐2, 3‐dihydro‐1‐oxo‐3‐phenyl‐1H, 5H‐pyrazolo [1, 2‐a]‐pyrazoles. Synthesis of rel‐(2R, 3R)‐3‐phenyl‐3‐[5‐aryl‐3, 4‐bis (methoxycarbonyl) pyrazolyl‐1] alanine esters
JPH09501954A (ja) イミダゾ［５，１−ｃ］［１，４］ベンゾキサジン−１−オンのイミダゾリルアルキル誘導体およびそれらの製造法
CZ119495A3 (en) 5,6-dihydro-4h-imidazo-£2,1,:2,3(imidazo)4,5,1-ij|quinoline derivatives and 4,5-dihydroimidazo£1,2-a(pyrrolo)1,2,3,-cd|benzimidazole derivatives, process of their preparation and pharmaceutical compositions containing such derivatives
KR20210092768A (ko) 1-((3s,4r)-4-(2,6-디플루오로-4-메톡시페닐)-2-옥소피롤리딘-3-일)-3-페닐우레아의 제조를 위한 합성 방법
AU2001258896A1 (en) A process for preparing pyrazolopyrimidinone derivatives for the treatment of impotence
Zubkov et al. Short approach to pyrrolopyrazino-, pyrrolodiazepino-isoindoles and their benzo analogues via the IMDAF reaction
Bric et al. Facile synthesis of 2-substituted ethyl 2-(2-amino-5-ethoxycarbonylthiazol-4-yl) ethanoates
FI85480B (fi) Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara b-karbolinderivat.
JPH072859A (ja) ピラゾール誘導体およびこれを有効成分とする医薬組成物

Legal Events

Date Code Title Description
MA Patent expired
MA Patent expired

Owner name: SYNTEX (U.S.A.) INC.